Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Financial Flexibility Index
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥298.34 Million (operating CF CN¥294.76 Million minus capex CN¥3.59 Million) represents 0% of total liabilities (CN¥3.00 Billion). Also explore 002424 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guizhou Bailing Group Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Guizhou Bailing Group Pharmaceutical Co Ltd across 19 annual periods. Check how strategically is Guizhou Bailing Group Pharmaceutical Co 's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Guizhou Bailing Group Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002424 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥873.96 Million | CN¥748.72 Million | CN¥3.02 Billion | ▲ +2129.6% |
| 2024 | 0.01x | CN¥51.04 Million | CN¥9.02 Million | CN¥3.94 Billion | ▼ -78.4% |
| 2023 | 0.06x | CN¥229.89 Million | CN¥125.77 Million | CN¥3.82 Billion | ▼ -69.5% |
| 2022 | 0.20x | CN¥570.60 Million | CN¥502.15 Million | CN¥2.90 Billion | ▼ -33.6% |
| 2021 | 0.30x | CN¥750.65 Million | CN¥324.92 Million | CN¥2.53 Billion | ▲ +187.1% |
| 2020 | 0.10x | CN¥321.80 Million | CN¥231.78 Million | CN¥3.11 Billion | ▼ -48.9% |
| 2019 | 0.20x | CN¥589.32 Million | CN¥467.41 Million | CN¥2.91 Billion | ▲ +1559.9% |
| 2018 | -0.01x | CN¥-28.43 Million | CN¥-157.45 Million | CN¥2.05 Billion | ▼ -108.4% |
| 2017 | 0.17x | CN¥224.57 Million | CN¥79.88 Million | CN¥1.36 Billion | ▼ -69.0% |
| 2016 | 0.53x | CN¥625.95 Million | CN¥466.62 Million | CN¥1.17 Billion | ▲ +16.2% |
| 2015 | 0.46x | CN¥534.27 Million | CN¥413.23 Million | CN¥1.16 Billion | ▲ +13.8% |
| 2014 | 0.40x | CN¥492.32 Million | CN¥395.83 Million | CN¥1.22 Billion | ▲ +137.2% |
| 2013 | 0.17x | CN¥230.50 Million | CN¥141.76 Million | CN¥1.35 Billion | ▲ +2.3% |
| 2012 | 0.17x | CN¥199.68 Million | CN¥19.52 Million | CN¥1.20 Billion | ▼ -54.5% |
| 2011 | 0.37x | CN¥394.98 Million | CN¥201.90 Million | CN¥1.08 Billion | ▲ +223.7% |
| 2010 | -0.30x | CN¥-281.99 Million | CN¥-447.68 Million | CN¥952.49 Million | ▼ -189.6% |
| 2009 | 0.33x | CN¥147.22 Million | CN¥125.31 Million | CN¥445.48 Million | ▲ +485.3% |
| 2008 | -0.09x | CN¥-27.51 Million | CN¥-40.42 Million | CN¥320.72 Million | ▲ +63.2% |
| 2007 | -0.23x | CN¥-73.70 Million | CN¥-79.37 Million | CN¥315.87 Million | — |